Danial Khorsandi
Danial Khorsandi has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Surjendu Maity
Terasaki Institute for Biomedical Innovation, Woodland Hills, CA, 91367, USA.; Department of Orthopedic Surgery, Duke University School of Medicine, Duke University, Durham, NC 27705, USA
2 shared publications Abdul Rahim Chethikkattuveli Salih
Terasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA
1 shared publication- Adrian Hanson
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90064, USA
1 shared publication - Ali Khademhosseini
Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA
1 shared publication - Alireza Hassani Najafabadi
Department of Pharmaceutical Sciences, University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH 45267, USA
1 shared publication - Arne Peirsman
Plastic, Reconstructive and Aesthetic Surgery, University Hospital Ghent, Corneel Heymanslaan 10, Gent, Oost-Vlaanderen, 9000, BELGIUM
1 shared publication
Latest Publications
- 14 August 2024
- Published by Royal Society of Chemistry (RSC)
- p. 560-614
Lab-on-a-chip: Unit Operations to Scale-up Strategies
This chapter provides an in-depth exploration of the key aspects of scaling up lab-on-a-chip (LOC) devices, a critical field of investigation with substantial implications for industrial production and clinical applications. It commences with a thorough understanding of unit operations in LOC devices, explaining their definition, significance, and types (i.e., fluid handling, sample preparation, and detection). Then, the chapter moves on to discuss the significant engineering challenges associated with the miniaturization of these unit operations, including technical difficulties, material and fabrication issues, and ensuring performance reliability and reproducibility. It presents effective strategies for the scaling up of LOC unit operations, covering essential technical considerations such as maintaining performance, enhancing throughput, and integrating operations. The section also includes a comprehensive view of successful scale-up projects, their approaches and outcomes, highlighting practical applications and results of these strategies. The chapter also navigates through regulatory and quality considerations in the scale-up process, underlining the importance of validation and standardization. Future directions and challenges in scaling up, including current limitations, potential solutions, and the impact of emerging technologies on scale-up processes, are highlighted to provide a glimpse into the promising, yet challenging, road ahead.
- 14 August 2024
- Published by Royal Society of Chemistry (RSC)
- p. 560-614
Lab-on-a-chip: Unit Operations to Scale-up Strategies
This chapter provides an in-depth exploration of the key aspects of scaling up lab-on-a-chip (LOC) devices, a critical field of investigation with substantial implications for industrial production and clinical applications. It commences with a thorough understanding of unit operations in LOC devices, explaining their definition, significance, and types (i.e., fluid handling, sample preparation, and detection). Then, the chapter moves on to discuss the significant engineering challenges associated with the miniaturization of these unit operations, including technical difficulties, material and fabrication issues, and ensuring performance reliability and reproducibility. It presents effective strategies for the scaling up of LOC unit operations, covering essential technical considerations such as maintaining performance, enhancing throughput, and integrating operations. The section also includes a comprehensive view of successful scale-up projects, their approaches and outcomes, highlighting practical applications and results of these strategies. The chapter also navigates through regulatory and quality considerations in the scale-up process, underlining the importance of validation and standardization. Future directions and challenges in scaling up, including current limitations, potential solutions, and the impact of emerging technologies on scale-up processes, are highlighted to provide a glimpse into the promising, yet challenging, road ahead.
- Open Access
- 29 April 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (5) , 978
Engineered Vasculature for Cancer Research and Regenerative Medicine
Engineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.
- 29 April 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (5) , 978
Open AccessEngineered Vasculature for Cancer Research and Regenerative Medicine
Engineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.